Related references
Note: Only part of the references are listed.Purification of clinical-grade disulfide stabilized antibody fragment variable-Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli
Hua Jiang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study
Jianghao Chen et al.
BMC CANCER (2013)
A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Chuanliang Cui et al.
MOLECULAR THERAPY (2013)
Batch production of a silk-elastin-like protein in E. coli BL21 (DE3): key parameters for optimisation
Tony Collins et al.
MICROBIAL CELL FACTORIES (2013)
A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer
Xin Zhao et al.
INVESTIGATIONAL NEW DRUGS (2012)
A tumor-penetrating peptide modification enhances the antitumor activity of endostatin in vivo
Zhang Hai-Tao et al.
ANTI-CANCER DRUGS (2011)
Significantly enhanced production of recombinant nitrilase by optimization of culture conditions and glycerol feeding
Jun-Feng Liu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
A role for heparan sulfate proteoglycans in Plasmodium falciparum sporozoite invasion of anopheline mosquito salivary glands
Jennifer S. Armistead et al.
BIOCHEMICAL JOURNAL (2011)
Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways
Yang Chen et al.
BLOOD (2011)
Binding patterns of peptide-containing liposomes in liver and spleen of developing mice: comparison with heparan sulfate immunoreactivity
Monica S. Tsai et al.
JOURNAL OF DRUG TARGETING (2011)
The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host
Alida Coppi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Expression of the antimicrobial peptide cecropin fused with human lysozyme in Escherichia coli
Xue-mei Lu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Quantitative and Qualitative Alterations of Heparan Sulfate in Fibrogenic Liver Diseases and Hepatocellular Cancer
Peter Tatrai et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
N-terminal modification increases the stability of the recombinant human endostatin in vitro
Li-Ping Jiang et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2009)
Liposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparan sulfate
Kenneth J. Longmuir et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Liposomes incorporating a Plasmodium amino acid sequence target heparan sulfate binding sites in liver
Richard T. Robertson et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Binding of endostatin to human ovarian cancer cells inhibits cell attachment
Yumi Yokoyama et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells
Yun Ling et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
High level expression of human endostatin in Pichia pastoris using a synthetic gene construct
Zhijian Su et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence
KJ Longmuir et al.
PHARMACEUTICAL RESEARCH (2006)
Expression, purification, and characterization of a neovasculature targeted rmhTNF-alpha in Escherichia coli
H Wang et al.
PROTEIN EXPRESSION AND PURIFICATION (2006)
Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer
AHG Hansma et al.
ANNALS OF ONCOLOGY (2005)
Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth
Y Yokoyama et al.
CANCER (2005)
Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells
ET Velde et al.
BRITISH JOURNAL OF CANCER (2005)
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
M Sund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting tumor angiogenic vasculature using polymer-RGD conjugates
A Mitra et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys
HF Song et al.
ACTA PHARMACOLOGICA SINICA (2005)
Endostatin's antiangiogenic signaling network
A Abdollahi et al.
MOLECULAR CELL (2004)
A binding site for highly sulfated heparan sulfate is identified in the N terminus of the circumsporozoite protein - Significance for malarial sporozoite attachment to hepatocytes
JB Ancsin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity
R Tewari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily
JP Eder et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Phase I study of recombinant human endostatin in patients with advanced solid tumors
RS Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
